1. Long COVID research needs patient peer review – not just patient quotes In a Lancet Infectious Diseases Comment, the authors argue that long COVID research systematically incorporates patient expertise via routine...
Download Infographic Overview Global vaccine production is estimated at approximately 14.5 billion doses annually. The global vaccine market reached around $35 billion in revenue in 2024–2025. Major global players...
Typhoid conjugate vaccine: primary target groups SAGE recommends introducing TCV in countries or settings with high or very high typhoid incidence, or with a substantial burden of antimicrobial-resistant S...
In 2021, surveillance systems in multiple countries detected a safety signal for myocarditis and pericarditis after mRNA COVID‑19 vaccination, particularly in adolescent and young adult males. Three years later, the...
Global / Multicontinental COVID-19 vaccine myocarditis signal: updated interpretation CIDRAP summarises current evidence that the early myocarditis signal with mRNA COVID-19 vaccines in young males was real but now...
Regulatory, policy, and manufacturer news WHO influenza vaccine composition: WHO issued its recommendations for the 2026–2027 Northern Hemisphere seasonal influenza vaccine composition on 26 February 2026, including the...
As the world reaches the midpoint of the Immunization Agenda 2030 (IA2030), immunization programs find themselves at an inflection point.1 The initial focus on recovering from pandemic-era backsliding is giving way to a...
What is EUVABECO? The EUVABECO project — short for European Vaccination Beyond COVID-19 — is a major initiative funded under the EU4Health programme, aiming to translate lessons from the COVID-19 pandemic into durable...
Evidence from leading journals since 2021 consistently documents both pronounced vaccine inequity between countries and substantial within‑country access gaps, especially for COVID‑19 but also for routine childhood...
In the last days, there have been notable developments in COVID‑19 vaccine formulations, WHO prequalification, and – as reported before – politically driven schedule changes in the US. Very recent product...